Dianthus Therapeutics Inc
DNTH43.770USD
+1.330+3.13%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
1.88BMarket Cap
LossP/E TTM
Dianthus Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
6.24M
120.63%
EPS(YoY)
-2.55
69.82%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its total revenue reached 6.24M, with a year-on-year change of 120.63%.
What is the Earnings Per Share (EPS) of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.551, with a year-on-year change of 69.82%.
What is the net income of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its net income was -84.97M, with a year-on-year change of -95.08%.
What is the net margin of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its net profit margin was -1362.77%, with a year-on-year change of 11.58%.
What is the gross margin of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -32.60%, with a year-on-year change of -2.84%.
What is the Return on Assets (ROA) of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -30.71%, with a year-on-year change of -14.94%.
What is the operating profit of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its operating profit was -101.86M, with a year-on-year change of -111.45%.
What are the current assets of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its current assets were 280.90M, with a year-on-year change of 58.30%.
What are the total assets of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its total assets of Dianthus Therapeutics Inc were 374.01M, with a year-on-year change of 108.47%.
What are the total liabilities of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its total liabilities of Dianthus Therapeutics Inc were 21.53M, with a year-on-year change of 104.38%.
What is the total equity of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its total equity of Dianthus Therapeutics Inc was 352.48M, with a year-on-year change of 108.73%.
What is the net operating income of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its net operating income of Dianthus Therapeutics Inc was -84.97M, with a year-on-year change of -95.08%.
What is the net investment of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its net investment of Dianthus Therapeutics Inc was -286.81M, with a year-on-year change of -1516.15%.
What is the net financing of Dianthus Therapeutics Inc?
According to Dianthus Therapeutics Inc's FY2024 earnings report, its net financing of Dianthus Therapeutics Inc was 255.62M, with a year-on-year change of 91.37%.
